Skip to content
logo-orbit-white
Main Menu
  • Training Courses
    • RRI Training
    • Trusted Research
    • Design of Ethical AI Systems
    • Stakeholder Engagement
    • Data Governance
    • Ethical Hackathons
    • Responsible Quantum Technologies
    • Environmentally Sustainable Research
  • Resources & Tools
    • AREA 4P Framework
    • The Keys of RRI
    • About RRI Maturity
    • Self Assessment Tool
    • Self Assessment Results
    • RRI Maturity
    • RRI Maturity Results
    • Action Plan
    • Action Plan Results
  • Services
  • News
  • Contact
Login

RRI Training

I

Trusted Research Training

I

Ethical AI Systems Training

I

Stakeholder Engagement

I

Data Governance

I

Sustainable Research

  • About ORBIT
    • AREA 4P Framework
    • The Keys of RRI
    • Employment Opportunities
  • Tools
  • Contact
  • Account
    • Workshop Hub
    • Your Courses
    • Organisation RRI Maturity Archive
    • RRI Intensity Level Archive
    • Your Action Plans
    • Delete Your Account
  • Embrace Course Booking
  • Journal
  • Toggle website search
Read more about the article Assessment of Recent Surge in Antengene Corporation Limited (6996.HK) Stock

Assessment of Recent Surge in Antengene Corporation Limited (6996.HK) Stock

On 5 March 2026, Antengene Corporation Limited (6996.HK) experienced a significant increase in its stock price, climbing by 34.03% to close at HKD 3.86 on the Hong Kong Stock Exchange.…

Read more about the article Sana Biotechnology Reports Expanded Q4 Net Loss and Future Milestones

Sana Biotechnology Reports Expanded Q4 Net Loss and Future Milestones

(RTTNews) - Sana Biotechnology, Inc. (SANA) has reported its financial results for the fourth quarter, revealing an expanded net loss. However, on an adjusted basis, the net loss has shown…

Read more about the article Theolytics Secures €8 Million Horizon Europe Grant to Propel Phase 2 Study of THEO-260 in Ovarian Cancer

Theolytics Secures €8 Million Horizon Europe Grant to Propel Phase 2 Study of THEO-260 in Ovarian Cancer

Theolytics, a clinical-stage biotechnology company focused on next-generation oncolytic immunotherapies, has been awarded €8 million in non-dilutive grant funding from Horizon Europe 2025, pending final negotiation. This funding is part…

Read more about the article Fellowship Opportunities in Pharma and Life Sciences at RCB

Fellowship Opportunities in Pharma and Life Sciences at RCB

The Regional Centre for Biotechnology (RCB) is an Institution of National Importance, established through an Act of the Indian Parliament by the Department of Biotechnology, Government of India, under the…

Read more about the article Korea to Host Inaugural Prix Galien Awards in Recognition of Pharmaceutical Innovations

Korea to Host Inaugural Prix Galien Awards in Recognition of Pharmaceutical Innovations

The Gallien Foundation is set to celebrate pharmaceutical advancements with the inaugural "Prix Galien Korea Awards" on September 10, 2023, at the prestigious Shilla Hotel in Seoul. This event marks…

Read more about the article Bharat Biotech International Limited Moves Towards Initial Public Offering

Bharat Biotech International Limited Moves Towards Initial Public Offering

Kolkata: Bharat Biotech International Limited, a prominent vaccine manufacturer in India, is reportedly preparing to engage with capital markets. The firm is contemplating a substantial initial public offering (IPO) that…

Read more about the article Fargo-Moorhead: A Hub of Economic Diversity with a Dozen Billion-Dollar Enterprises

Fargo-Moorhead: A Hub of Economic Diversity with a Dozen Billion-Dollar Enterprises

FARGO — Fargo-Moorhead is distinguished by the presence of a dozen billion-dollar enterprises, a fact that economic leaders attribute not only to the scale of these corporations but also to…

Read more about the article SIMRIS_B: Revenue Decline and Liquidity Challenges Amid Biotech Transition

SIMRIS_B: Revenue Decline and Liquidity Challenges Amid Biotech Transition

SIMRIS_B has reported a significant drop in net revenue, which decreased by 44% year-over-year. Despite improvements in EBITDA and EBIT, the company is grappling with negative equity and cash flow…

Read more about the article Generate Biomedicines Achieves Fundraising Milestone Amidst Share Price Decline

Generate Biomedicines Achieves Fundraising Milestone Amidst Share Price Decline

Generate Biomedicines has successfully achieved its fundraising objective during its initial public offering (IPO), which took place on February 27, 2026. The IPO was priced within the anticipated range, thereby…

Read more about the article Ensysce Biosciences Sees Share Surge Amid Strategic Review

Ensysce Biosciences Sees Share Surge Amid Strategic Review

Ensysce Biosciences (NASDAQ:ENSC) has witnessed a significant increase in its share price on Friday, following the announcement of a strategic review aimed at enhancing shareholder value. On Wednesday, the company…

  • Go to the previous page
  • 1
  • …
  • 10
  • 11
  • 12
  • 13
  • 14
  • Go to the next page

Course Information

Help & Information

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact

Contact Us

  • contact@orbit-rri.org
  • @orbitrri
  • @orbitrri

Training & Workshops

AI Empowerment

Stakeholder Engagement

Trusted Research

Data Governance

Ethical Hackathons

RRI Training

Responsible Quantum Technologies

Environmentally Sustainable Research

Design of Ethical AI Systems

  • About ORBIT
  • Terms & Conditions
  • Privacy Policy
  • Data Breach Policy
  • Contact
Copyright 2023 - ORBIT RRI a not for profit company.

By continuing to use this website, you consent to the use of cookies in accordance with our Cookie Policy.

Accept